Tecan Group (Switzerland) Insiders
| TECN Stock | CHF 206.00 1.60 0.77% |
Tecan Group employs about 3 K people. The company is managed by 8 executives with a total tenure of roughly 7000 years, averaging almost 875.0 years of service per executive, having 375.0 employees per reported executive. Recap of Tecan Group's management performance can provide insight into the venture performance.
| Achim Leoprechting Insider CEO Board |
| Wael Yared Insider Ex CTO |
Tecan |
Tecan Group Management Team Effectiveness
The company has return on total asset (ROA) of 0.0488 % which means that it generated a profit of $0.0488 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0981 %, meaning that it generated $0.0981 on every $100 dollars invested by stockholders. Tecan Group's management efficiency ratios could be used to measure how well Tecan Group manages its routine affairs as well as how well it operates its assets and liabilities.Tecan Group Workforce Comparison
Tecan Group AG is currently regarded as top stock in number of employees category among its peers. The total workforce of Medical Devices industry is at this time estimated at about 34,526. Tecan Group holds roughly 3,000 in number of employees claiming about 9% of all equities under Medical Devices industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.12 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.12. Tecan Group AG Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Tecan Group AG Price Series Summation is a cross summation of Tecan Group price series and its benchmark/peer.
Tecan Group Notable Stakeholders
A Tecan Group stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Tecan Group often face trade-offs trying to please all of them. Tecan Group's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Tecan Group's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Achim Leoprechting | CEO Board | Profile | |
| Wael Yared | Ex CTO | Profile | |
| Ralf Griebel | Head VP | Profile | |
| Andreas Wilhelm | Gen VP | Profile | |
| Martin Brandle | Sr Board | Profile | |
| MBA MSc | Member VP | Profile | |
| Gunter Weisshaar | Head VP | Profile | |
| Ulrich Kanter | Global VP | Profile |
About Tecan Group Management Performance
The success or failure of an entity such as Tecan Group AG often depends on how effective the management is. Tecan Group management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Tecan management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Tecan management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Tecan Group Ltd. provides laboratory instruments and solutions for pharmaceutical and biotechnology companies, university research departments, and forensic and diagnostic laboratories. Tecan Group Ltd. was founded in 1980 and is headquartered in Mnnedorf, Switzerland. TECAN GROUP operates under Medical Devices classification in Switzerland and is traded on Switzerland Exchange. It employs 1662 people.
Please note, the imprecision that can be found in Tecan Group's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Tecan Group AG. Check Tecan Group's Beneish M Score to see the likelihood of Tecan Group's management manipulating its earnings.
Tecan Group Workforce Analysis
Traditionally, organizations such as Tecan Group use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Tecan Group within its industry.Tecan Group Manpower Efficiency
Return on Tecan Group Manpower
| Revenue Per Employee | 315.5K | |
| Revenue Per Executive | 118.3M | |
| Net Income Per Employee | 40.6K | |
| Net Income Per Executive | 15.2M |
Additional Tools for Tecan Stock Analysis
When running Tecan Group's price analysis, check to measure Tecan Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tecan Group is operating at the current time. Most of Tecan Group's value examination focuses on studying past and present price action to predict the probability of Tecan Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tecan Group's price. Additionally, you may evaluate how the addition of Tecan Group to your portfolios can decrease your overall portfolio volatility.